Musculoskeletal Soft-tissue Masses

Burke, Christopher; Fritz, Jan; Samim, Mohammad

doi:10.1016/j.mric.2022.10.001

Cited by 3 publications

(2 citation statements)

References 105 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…16). When MRI is performed following US examination, it can be tailored to address specific unanswered questions (31) . For example, if the tumor is hypervascular on US, there is often no need to undertake contrastenhanced MRI to assess tumor perfusion (31) .…”

Section: When Is Mri Necessary?mentioning

confidence: 99%

“…When MRI is performed following US examination, it can be tailored to address specific unanswered questions (31) . For example, if the tumor is hypervascular on US, there is often no need to undertake contrastenhanced MRI to assess tumor perfusion (31) . Large deep soft tissue sarcomas (STS) should be evaluated by MRI, primarily to define tumor location and NVB involvement (Fig.…”

Section: When Is Mri Necessary?mentioning

confidence: 99%

See 1 more Smart Citation

Practical approach to ultrasound of soft tissue tumors and the added value of MRI: how I do it

Griffith

2023

J Ultrason

View full text Add to dashboard Cite

This review outlines a practical approach to the everyday assessment of both non-neoplastic and neoplastic soft tissue tumors, focusing on ultrasound examination, though emphasizing the added benefit of magnetic resonance imaging in certain instances. Ultrasound approach and assessment, practical scenarios, report- ing, biopsy, and follow-up are covered, as well as the criteria used to distinguish benign from malignant tumors. The potential benefits and current limitations of elastography and contrast-enhanced ultrasound in assessment are also addressed. Examples of commonly encountered soft tissue tumors are shown. Ul- trasound can characterize most soft tissue masses based on their ultrasound appearance alone. Following ultrasound examination, three potential scenarios usually exist in clinical practice: (a) confident regarding diagnosis, (b) indeterminate mass with no evidence of malignancy, and (c) indeterminate mass with pos- sibility of malignancy. A diagnostic pathway for each of these scenarios is provided. Magnetic resonance imaging is generally not helpful in further characterizing masses which are indeterminate on ultrasound assessment, though it is helpful in addressing other issues such as exact tumor location and neurovascular bundle involvement that may not be fully resolved on ultrasound examination. In these situations, mag- netic resonance imaging examination can be tailored to address those specific questions that have not been adequately addressed on ultrasound examination. In this sense, both examinations are highly complemen- tary. Tips for undertaking magnetic resonance imaging examinations are provided.

show abstract

Section: When Is Mri Necessary?mentioning

confidence: 99%

Section: When Is Mri Necessary?mentioning

confidence: 99%

Practical approach to ultrasound of soft tissue tumors and the added value of MRI: how I do it

Griffith

2023

J Ultrason

View full text Add to dashboard Cite

show abstract

Sclerosing well-differentiated liposarcoma: two diagnostically challenging mimicker cases and a literature review

Noorily,

Hoda,

Mantilla

et al. 2024

Skeletal Radiol

View full text Add to dashboard Cite

A practical risk stratification system based on ultrasonography and clinical characteristics for predicting the malignancy of soft tissue masses

Zhang,

Wu,

et al. 2024

Insights Imaging

View full text Add to dashboard Cite

Objective To establish a practical risk stratification system (RSS) based on ultrasonography (US) and clinical characteristics for predicting soft tissue masses (STMs) malignancy. Methods This retrospective multicenter study included patients with STMs who underwent US and pathological examinations between April 2018 and April 2023. Chi-square tests and multivariable logistic regression analyses were performed to assess the association of US and clinical characteristics with the malignancy of STMs in the training set. The RSS was constructed based on the scores of risk factors and validated externally. Results The training and validation sets included 1027 STMs (mean age, 50.90 ± 16.64, 442 benign and 585 malignant) and 120 STMs (mean age, 51.93 ± 17.90, 69 benign and 51 malignant), respectively. The RSS was constructed based on three clinical characteristics (age, duration, and history of malignancy) and six US characteristics (size, shape, margin, echogenicity, bone invasion, and vascularity). STMs were assigned to six categories in the RSS, including no abnormal findings, benign, probably benign (fitted probabilities [FP] for malignancy: 0.001–0.008), low suspicion (FP: 0.008–0.365), moderate suspicion (FP: 0.189–0.911), and high suspicion (FP: 0.798–0.999) for malignancy. The RSS displayed good diagnostic performance in the training and validation sets with area under the receiver operating characteristic curve (AUC) values of 0.883 and 0.849, respectively. Conclusion The practical RSS based on US and clinical characteristics could be useful for predicting STM malignancy, thereby providing the benefit of timely treatment strategy management to STM patients. Critical relevance statement With the help of the RSS, better communication between radiologists and clinicians can be realized, thus facilitating tumor management. Key Points There is no recognized grading system for STM management. A stratification system based on US and clinical features was built. The system realized great communication between radiologists and clinicians in tumor management. Graphical Abstract

show abstract

Musculoskeletal Soft-tissue Masses

Cited by 3 publications

References 105 publications

Practical approach to ultrasound of soft tissue tumors and the added value of MRI: how I do it

Practical approach to ultrasound of soft tissue tumors and the added value of MRI: how I do it

Sclerosing well-differentiated liposarcoma: two diagnostically challenging mimicker cases and a literature review

A practical risk stratification system based on ultrasonography and clinical characteristics for predicting the malignancy of soft tissue masses

Contact Info

Product

Resources

About